Tag Archives: Valganciclovir

Stanford University’s ME/CFS research

Researchers are making headway toward finding evidence of chronic fatigue syndrome and how it may change the brain. Ronald W. Davis, a Stanford University genetics researcher who was instrumental in the Human Genome Project, is heading up a new research … Continue reading

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on Stanford University’s ME/CFS research

Valganciclovir is potential treatment for CFS subset

Research abstract  There is no known treatment for chronic fatigue syndrome (CFS). Little is known about its pathogenesis. Human herpesvirus 6 (HHV-6) and Epstein–Barr virus (EBV) have been proposed as infectious triggers. Method: Thirty CFS patients with elevated IgG antibody … Continue reading

Posted in News | Tagged , , , | Comments Off on Valganciclovir is potential treatment for CFS subset

Antiviral valganciclovir helps CFS subgroup

In a study by Dr Jose Montoya in the USA half of CFS patients suffering from HHV-6 and EBV viruses make an improvement of 30% or more. Abstract Valganciclovir has been reported to improve physical and cognitive symptoms in patients … Continue reading

Posted in News | Tagged , , , , , , | Comments Off on Antiviral valganciclovir helps CFS subgroup